These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

936 related items for PubMed ID: 16194586

  • 1. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC, Clark HJ, Clark RC, Olsen CW, Townsend HG, Lunn DP.
    Vaccine; 2006 Feb 20; 24(8):1180-90. PubMed ID: 16194586
    [Abstract] [Full Text] [Related]

  • 2. Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination.
    Breathnach CC, Rudersdorf R, Lunn DP.
    Vet Immunol Immunopathol; 2004 Apr 20; 98(3-4):127-36. PubMed ID: 15010222
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM, Toulemonde CE, Coupier H, Guigal PM, Dinic S, Sindle T, Jessett D, Black L, Bublot M, Pardo MC, Audonnet JC.
    Am J Vet Res; 2007 Feb 20; 68(2):213-9. PubMed ID: 17269889
    [Abstract] [Full Text] [Related]

  • 4. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses.
    Crouch CF, Daly J, Henley W, Hannant D, Wilkins J, Francis MJ.
    Vet Immunol Immunopathol; 2005 Dec 15; 108(3-4):345-55. PubMed ID: 16098611
    [Abstract] [Full Text] [Related]

  • 5. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
    Paillot R, Kydd JH, Sindle T, Hannant D, Edlund Toulemonde C, Audonnet JC, Minke JM, Daly JM.
    Vet Immunol Immunopathol; 2006 Aug 15; 112(3-4):225-33. PubMed ID: 16621023
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
    Paillot R, Prowse L, Donald C, Medcalf E, Montesso F, Bryant N, Watson J, Jeggo M, Elton D, Newton R, Trail P, Barnes H.
    Vet Immunol Immunopathol; 2010 Aug 15; 136(3-4):272-83. PubMed ID: 20400185
    [Abstract] [Full Text] [Related]

  • 7. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
    Crouch CF, Daly J, Hannant D, Wilkins J, Francis MJ.
    Vaccine; 2004 Dec 02; 23(3):418-25. PubMed ID: 15530689
    [Abstract] [Full Text] [Related]

  • 8. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R, Grimmett H, Elton D, Daly JM.
    Vet Res; 2008 Dec 02; 39(3):21. PubMed ID: 18252187
    [Abstract] [Full Text] [Related]

  • 9. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination.
    Soboll G, Hussey SB, Minke JM, Landolt GA, Hunter JS, Jagannatha S, Lunn DP.
    Vet Immunol Immunopathol; 2010 May 15; 135(1-2):100-107. PubMed ID: 20018384
    [Abstract] [Full Text] [Related]

  • 10. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
    Van de Walle GR, May MA, Peters ST, Metzger SM, Rosas CT, Osterrieder N.
    Vaccine; 2010 Jan 22; 28(4):1048-55. PubMed ID: 19897066
    [Abstract] [Full Text] [Related]

  • 11. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G, Hussey SB, Whalley JM, Allen GP, Koen MT, Santucci N, Fraser DG, Macklin MD, Swain WF, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):81-95. PubMed ID: 16549215
    [Abstract] [Full Text] [Related]

  • 12. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
    Lopez AM, Hecker R, Mutwiri G, van Drunen Littel-van den Hurk S, Babiuk LA, Townsend HG.
    Vet Immunol Immunopathol; 2006 Nov 15; 114(1-2):103-10. PubMed ID: 16950519
    [Abstract] [Full Text] [Related]

  • 13. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P, Luo M, Pan R, Ling D, Zhou S, Tien P, Pan Z.
    Antiviral Res; 2009 Mar 15; 81(3):253-60. PubMed ID: 19135483
    [Abstract] [Full Text] [Related]

  • 14. Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene.
    Lunn DP, Soboll G, Schram BR, Quass J, McGregor MW, Drape RJ, Macklin MD, McCabe DE, Swain WF, Olsen CW.
    Vaccine; 1999 May 04; 17(18):2245-58. PubMed ID: 10403592
    [Abstract] [Full Text] [Related]

  • 15. Humoral and cell-mediated immune responses of old horses following recombinant canarypox virus vaccination and subsequent challenge infection.
    Adams AA, Sturgill TL, Breathnach CC, Chambers TM, Siger L, Minke JM, Horohov DW.
    Vet Immunol Immunopathol; 2011 Feb 15; 139(2-4):128-40. PubMed ID: 21035197
    [Abstract] [Full Text] [Related]

  • 16. Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.
    Kreijtz JH, Suezer Y, van Amerongen G, de Mutsert G, Schnierle BS, Wood JM, Kuiken T, Fouchier RA, Lower J, Osterhaus AD, Sutter G, Rimmelzwaan GF.
    J Infect Dis; 2007 Jun 01; 195(11):1598-606. PubMed ID: 17471429
    [Abstract] [Full Text] [Related]

  • 17. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein.
    James CM, Abdad MY, Mansfield JP, Jacobsen HK, Vind AR, Stumbles PA, Bartlett EJ.
    Vaccine; 2007 Feb 26; 25(10):1856-67. PubMed ID: 17240000
    [Abstract] [Full Text] [Related]

  • 18. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
    Daly JM, Yates PJ, Newton JR, Park A, Henley W, Wood JL, Davis-Poynter N, Mumford JA.
    Vaccine; 2004 Sep 28; 22(29-30):4101-9. PubMed ID: 15364463
    [Abstract] [Full Text] [Related]

  • 19. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P, Parker M, Ludwig GV, Davis NL, Johnston RE, Smith JF.
    Virology; 1997 Dec 22; 239(2):389-401. PubMed ID: 9434729
    [Abstract] [Full Text] [Related]

  • 20. Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine.
    Minke JM, Toulemonde CE, Dinic S, Cozette V, Cullinane A, Audonnet JC.
    J Comp Pathol; 2007 Jul 22; 137 Suppl 1():S76-80. PubMed ID: 17559865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.